Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if backed by outcomes, herald a “new age” of care, suggests a landmark trial.

There have been 258 placebo-controlled clinical trials of vaccines, according to a new research project. More than half of ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

Coherus Oncology, Inc. (Coherus Oncology, Nasdaq: CHRS), a commercial-stage innovative oncology company, formerly named Coherus BioSciences Inc.

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

Stem cells can fight disease from the inside out. But not all treatments are created equal. The promise of stem cell therapy ...

VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the ...

Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong ...

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its ...

Tonmoy Sharma, a 61-year-old doctor from Guwahati has been arrested in the US over an alleged $149-million healthcare fraud.

At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, from May 30 to June 3, the results of the Phase Ib/II clinical study of 9MW2821 in combination with ...